2021
DOI: 10.1155/2021/4341517
|View full text |Cite
|
Sign up to set email alerts
|

Network Pharmacology-Based Analysis of the Effects of Corydalis decumbens (Thunb.) Pers. in Non-Small Cell Lung Cancer

Abstract: Non-small cell lung cancer (NSCLC) is one of the most malignant tumors worldwide. The main treatment for NSCLC is based on Western medicine; however, the overall effect is unsatisfactory. This study aimed to investigate the potential therapeutic targets and pharmacological mechanisms of action of the traditional Chinese medicine Corydalis decumbens (Thunb.) Pers. in NSCLC based on network pharmacology and bioinformatics. The overlapping genes between Corydalis decumbens (Thunb.) Pers. and NSCLCs were screened … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 28 publications
0
3
0
Order By: Relevance
“…In addition, we performed gene enrichment to speculate on the potential mechanism of MFG-E8. KEGG analysis showed that MFG-E8 was associated with Neuroactive ligand-receptor interaction, cAMP signaling pathway, and Cholinergic synapse [ 26 , 27 ]. The cAMP signaling pathway is a classical oncogenic pathway [ 28 ].…”
Section: Discussionmentioning
confidence: 99%
“…In addition, we performed gene enrichment to speculate on the potential mechanism of MFG-E8. KEGG analysis showed that MFG-E8 was associated with Neuroactive ligand-receptor interaction, cAMP signaling pathway, and Cholinergic synapse [ 26 , 27 ]. The cAMP signaling pathway is a classical oncogenic pathway [ 28 ].…”
Section: Discussionmentioning
confidence: 99%
“…Although it was suggested that HSP90AA1 could be a potential target for NSCLC treatment, another protein-coding gene, NCOA2, might be relevant for gastric cancer, liver cancer, or prostate cancer [ 46 48 ]. Although many previous studies have hypothesized that NCOA2 might become a potential therapeutic target for NSCLC, further verification is still needed to validate it [ 49 ]. PPARG expression may also act as a potential therapeutic agent for NSCLC, especially for lung squamous cell carcinoma (LSCC), since the activation of PPARG expression can inhibit LSCC development and progress by regulating the upstream regulator and downstream marker genes, which are involved in tumor cell proliferation and protein polyubiquitination/ubiquitination [ 50 ].…”
Section: Discussionmentioning
confidence: 99%
“…Using bioinformatics to screen antitumor medicines can improve the efficiency of drug screening. Some scholars previously used bioinformatics methods to filter the key biomarkers and therapeutic targets for LUSC, 9 however, most experiments have not been further verified.…”
Section: Introductionmentioning
confidence: 99%